OS Therapies OSTX
NYSE OSTX
$1.27 -0.01 (-0.78%)
At close: Oct 22, 2026 · 4:00 PM EDT

OS Therapies (OSTX) Amortization of Deferred Charges (2023 - 2026)

Updated

Analysis

OS Therapies (OSTX) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,139.57 Bn 1,108.15 Bn 19.71 Bn
2 Johnson & Johnson 634.50 Bn 554.36 Bn 17.30 Bn
3 AbbVie 500.91 Bn 474.02 Bn 12.70 Bn
4 Merck 355.88 Bn 310.26 Bn 12.21 Bn
5 Novartis Ag 300.26 Bn 264.25 Bn 11.24 Bn
6 Astrazeneca 263.05 Bn 236.74 Bn 12.86 Bn
7 Amgen 237.74 Bn 193.14 Bn 7.24 Bn
8 Gilead Sciences 194.00 Bn 168.19 Bn 6.22 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn
10 OS Therapies 5.97 Mn 2.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,109.00
Mar 31, 2026 68,972.00
Mar 31, 2025 -1.12 Mn
Sep 30, 2024 338,289.00
Jun 30, 2024 508,654.00
Mar 31, 2024 578,736.00
Dec 31, 2023 213,235.00
Sep 30, 2023 981,143.00
Jun 30, 2023 835,928.00
Mar 31, 2023 616,153.00
API Access

OS Therapies Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=OSTX&period=max&api_key=YOUR_API_KEY